AtaiBeckley Inc. (ATAI)
NASDAQ: ATAI · Real-Time Price · USD
3.640
-0.070 (-1.89%)
At close: Jan 16, 2026, 4:00 PM EST
3.590
-0.050 (-1.37%)
Pre-market: Jan 20, 2026, 7:45 AM EST
AtaiBeckley Market Cap
AtaiBeckley has a market cap or net worth of $1.32 billion as of January 20, 2026. Its market cap has increased by 492.36% in one year.
Market Cap
1.32B
Enterprise Value
1.21B
1-Year Change
492.36%
Ranking
Category
Stock Price
$3.64
Market Cap Chart
Since the IPO on June 18, 2021, AtaiBeckley's market cap has decreased from $2.29B to $1.32B, a decrease of -42.23%. That is a compound annual growth rate of -11.28%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 16, 2026 | 1.32B | -11.00% |
| Dec 31, 2025 | 1.49B | 565.59% |
| Dec 31, 2024 | 223.18M | -4.66% |
| Dec 29, 2023 | 234.07M | -46.95% |
| Dec 30, 2022 | 441.23M | -63.92% |
| Dec 31, 2021 | 1.22B | -46.56% |
| Jun 18, 2021 | 2.29B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 929.76B |
| Johnson & Johnson | 526.82B |
| AbbVie | 378.84B |
| UnitedHealth Group | 299.85B |
| AstraZeneca | 289.32B |
| Novartis AG | 278.23B |
| Merck & Co. | 270.12B |
| Novo Nordisk | 261.50B |